Daewoong Pharma
KRX:069620

Watchlist Manager
Daewoong Pharma Logo
Daewoong Pharma
KRX:069620
Watchlist
Price: 187 300 KRW 2.24%
Market Cap: 2.2T KRW

Net Margin
Daewoong Pharma

5.1%
Current
5%
Average
4.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.1%
=
Net Income
75.1B
/
Revenue
1.5T

Net Margin Across Competitors

Country Company Market Cap Net
Margin
KR
Daewoong Pharma
KRX:069620
2.2T KRW
5%
US
Eli Lilly and Co
NYSE:LLY
939.8B USD
31%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
-4%
US
Johnson & Johnson
NYSE:JNJ
497B USD
27%
CH
Roche Holding AG
SIX:ROG
256.4B CHF
15%
UK
AstraZeneca PLC
LSE:AZN
209.6B GBP
16%
CH
Novartis AG
SIX:NOVN
201.7B CHF
26%
US
Merck & Co Inc
NYSE:MRK
242.8B USD
30%
DK
Novo Nordisk A/S
CSE:NOVO B
1.4T DKK
33%
IE
Endo International PLC
LSE:0Y5F
202.5B USD
-126%
US
Pfizer Inc
NYSE:PFE
146.6B USD
16%
No Stocks Found

Daewoong Pharma
Glance View

Market Cap
2.2T KRW
Industry
Pharmaceuticals

Daewoong Pharmaceutical Co., Ltd. engages in the manufacture and sale of pharmaceuticals. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2002-11-01. The firm's products mainly include antihypertensive drugs, antianemic agents, antidiabetic agents, antiemetic agents, antihistamine agents, antimicrobials, antineoplastics, antiobesity agents, antipyretic agents, analgesic agents, anti-inflammatory agents, biosimilars, remedies for bone and joint diseases, cardiovascular treatments, central nervous system treatments, digestive agents, dermatologic agents, gastrointestinal agents, health supplements and respiratory remedies, among others. The firm distributes its products in domestic and overseas markets.

Daewoong Pharma Intrinsic Value
HIDDEN
Show
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
5.1%
=
Net Income
75.1B
/
Revenue
1.5T
What is the Net Margin of Daewoong Pharma?

Based on Daewoong Pharma's most recent financial statements, the company has Net Margin of 5.1%.

Back to Top